JOURNAL OF THE CZECH PHARMACEUTICAL SOCIETY AND THE SLOVAK PHARMACEUTICAL SOCIETY

Čes. slov. farm. 2008, 57(2):58-62

Interaction of 1,4-dihydropyridines with ion channels

L. Veizerová*, J. Světlík, V. Kettmann
Univerzita Komenského, Farmaceutická fakulta, Katedra farmaceutickej analýzy a nukleárnej farmácie, Bratislava

The pharmacology of dihydropyridines in the cardiovascular system is widely known and the effects on L-type channels are well researched. There is far less information about the action of dihydropyridines on other classes of voltage-gated calcium channels. This article aims to bring more information about dihydropyridine derivates action on voltage-gated calcium channels or on Na+ a K+channels.

Keywords: Ca2+ channels; N-channel blockers; T-channel blockers; 1,4-dihydropyridines
Grants and funding:

Práca bola realizovaná v rámci grantových projektov 1/4298/07 a 1/4299/07 VEGA Ministerstva školstva SR a grantu UK 45/2007.

Received: December 3, 2007; Accepted: January 14, 2008; Published: February 1, 2008  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Veizerová L, Světlík J, Kettmann V. Interaction of 1,4-dihydropyridines with ion channels. Čes. slov. farm. 2008;57(2):58-62.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Caterrall, W. A.: Pharmacol. Rev., 2005; 57, 411-425. Go to original source... Go to PubMed...
    2. Josephson, I. R. et al.: Biophys. J., 2002; 83, 2575-2586. Go to original source... Go to PubMed...
    3. Triggle, D. J.: Drug. Dev. Res., 2003; 58, 5-17. Go to original source...
    4. Ertel, E. A. et al.: Neuron, 2000; 25, 533-535. Go to original source... Go to PubMed...
    5. Hofmann, F. et al.: Rev. Biochem. Physiol., 1999; 139, 33-88. Go to original source... Go to PubMed...
    6. Yu, F. H., Catterall, W. A.: Sci. STKE, 2004; 253, 15.
    7. Tanaka, H., Shigenobu, K.: J. Pharmacol. Sci., 2005; 99, 214-220. Go to original source... Go to PubMed...
    8. Hamid, J. et al.: Neuroscience, 2006; 143, 717-728. Go to original source... Go to PubMed...
    9. Ono, K., Iijima, T.: J. Pharmacol. Sci., 2005; 99, 197-204. Go to original source... Go to PubMed...
    10. Vitko, I. et al.: J. Neurosci., 2005; 25, 4844-4855. Go to original source... Go to PubMed...
    11. Splawski, I. et al.: J. Biol. Chem., 2006; 281 (31), 22085-22091. Go to original source... Go to PubMed...
    12. Yunker, A. M. R.: J. Bioenerg. Biomembr., 2003; 35, 6, 577-598. Go to original source... Go to PubMed...
    13. Hagivara, N. et al.: J. Physiol., 1988; 395, 233-253. Go to original source... Go to PubMed...
    14. Heady, T. N. et al.: Jpn. J. Pharmacol., 2001; 85, 339-350. Go to original source... Go to PubMed...
    15. Masuda, Y. et al.: Cardiovasc. Drug Rev., 1994; 12, 123-135. Go to original source...
    16. Masumiya, H. et al.: Eur. J. Pharmacol., 1998; 349, 351-357. Go to original source... Go to PubMed...
    17. Furukawa, T. et al.: Br. J. Pharmacol., 2004; 143, 1050-1057. Go to original source... Go to PubMed...
    18. Tanaka, H. et al.: J. Pharmacol. Sci., 2004; 96, 499-501. Go to original source... Go to PubMed...
    19. Kumar, P. H. et al.: Mol. Pharmacol., 2002; 61, 649-658. Go to original source... Go to PubMed...
    20. Triggle, D. J.: Mini Rev. Med. Chem, 2003; 3, 215-223. Go to original source... Go to PubMed...
    21. Yamamoto, T. et al.: Bioorg. Med. Chem. Lett., 2006; 16, 798-802. Go to original source... Go to PubMed...
    22. Mori, Y. et al.: Trends Cardiovasc. Med., 2002; 12, 270-275. Go to original source... Go to PubMed...
    23. Saegusa, H. et al.: T. EMBO J., 2001; 20, 2349-2354. Go to original source... Go to PubMed...
    24. Perez-Pinzon, M. A. et al.: J. Neurol. Sci., 1997; 153, 22-28. Go to original source...
    25. Doering, C. J., Zamponi, G. W.: J. Bioenerg. Biomembr., 2003; 35 (6), 491-505. Go to original source... Go to PubMed...
    26. Hu, L. Y. et al.: J. Med. Chem., 1999; 42, 4239-4249. Go to original source... Go to PubMed...
    27. Roullet, J. B. et al.: J. Biol. Chem., 1999; 274, 25439-25446. Go to original source... Go to PubMed...
    28. Murai, Y. et al.: Brain Res., 2000; 854, 6-10. Go to original source... Go to PubMed...
    29. Murakami, M. et al.: Eur. J. Pharmacol., 2000; 419, 175-181.
    30. Hu, W. Y. et al.: J. Cardiovas. Pharmacol., 2001; 38, 450-459. Go to original source... Go to PubMed...
    31. Uneyama, H. et al.: Eur. J. Pharmacol., 1999; 373, 93-100. Go to original source... Go to PubMed...
    32. Takahara, A. et al.: Hypertens. Res., 2003; 26, 741-752.
    33. Altier, Ch., Zamponi, G. W.: Trends Pharmacol. Sci., 2004; 29, 465-470. Go to original source... Go to PubMed...
    34. Mintz, I. M. et al.: Nature, 1992; 355, 827-829. Go to original source... Go to PubMed...
    35. Newcomb, N. et al.: Biochemistry, 1998; 37, 15353-15362. Go to original source... Go to PubMed...
    36. Bourinet, E. et al.: Biophys. J., 2001; 81, 79-88. Go to original source...
    37. Ellory, J. C. et al.: FEBS Letts., 1992; 296, 219-221.
    38. Ellory, J. C. et al.: Brit. J. Pharmacol., 1994; 111, 903-905. Go to original source... Go to PubMed...
    39. Klockner, U. et al.: Brit. J. Pharmacol., 1989; 97, 957-967. Go to original source... Go to PubMed...
    40. Longman, S. D. et al.: Med. Res. Rev., 1992; 35, 2327-2340. Go to original source... Go to PubMed...
    41. Li, J. H.: Cardiovascular Drug Reviews, 1997; 15, 220-231. Go to original source...
    42. Yagupolskii, L. M. et al.: J. Med. Chem., 1999; 42, 5266-5271. Go to original source... Go to PubMed...
    43. Kohlhardt, M. et al.: Naunyn-Schmied. Arch. Pharmacol., 1989; 340, 210-218. Go to original source... Go to PubMed...
    44. Yatani, A. et al.: Circ. Res., 1985; 57, 868-875. Go to original source... Go to PubMed...
    45. Haleen, S. J. et al.: J. Pharmacol. Exp. Therap., 1989; 250, 22-30. Go to original source...

    Return to the content


    Czech and Slovak Pharmacy

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.